M&R Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $48.9K | Buy |
411
+297
| +261% | +$35.4K | 0.01% | 238 |
|
|
2024
Q2 | $16.3K | Hold |
114
| – | – | ﹤0.01% | 317 |
|
|
2024
Q1 | $14.6K | Sell |
114
-918
| -89% | -$118K | ﹤0.01% | 329 |
|
|
2023
Q4 | $107K | Buy |
1,032
+354
| +52% | +$36.6K | 0.03% | 192 |
|
|
2023
Q3 | $61.7K | Sell |
678
-132
| -16% | -$12K | 0.02% | 220 |
|
|
2023
Q2 | $65.5K | Buy |
+810
| New | +$65.5K | 0.02% | 222 |
|
|
2021
Q1 | – | Sell |
-750
| Closed | -$26K | – | 430 |
|
|
2020
Q4 | $26K | Hold |
750
| – | – | 0.01% | 282 |
|
|
2020
Q3 | $26K | Hold |
750
| – | – | 0.01% | 293 |
|
|
2020
Q2 | $24K | Hold |
750
| – | – | 0.01% | 297 |
|
|
2020
Q1 | $22K | Hold |
750
| – | – | 0.01% | 298 |
|
|
2019
Q4 | $21K | Hold |
750
| – | – | ﹤0.01% | 332 |
|
|
2019
Q3 | $19K | Hold |
750
| – | – | ﹤0.01% | 355 |
|
|
2019
Q2 | $19K | Hold |
750
| – | – | ﹤0.01% | 361 |
|
|
2019
Q1 | $18K | Hold |
750
| – | – | ﹤0.01% | 366 |
|
|
2018
Q4 | $17K | Hold |
750
| – | – | ﹤0.01% | 362 |
|
|
2018
Q3 | $17K | Hold |
750
| – | – | ﹤0.01% | 398 |
|
|
2018
Q2 | $17K | Sell |
750
-490
| -40% | -$11.1K | ﹤0.01% | 389 |
|
|
2018
Q1 | $30K | Hold |
1,240
| – | – | 0.01% | 349 |
|
|
2017
Q4 | $33K | Buy |
1,240
+490
| +65% | +$13K | 0.01% | 337 |
|
|
2017
Q3 | $18K | Hold |
750
| – | – | ﹤0.01% | 390 |
|
|
2017
Q2 | $17K | Hold |
750
| – | – | ﹤0.01% | 395 |
|
|
2017
Q1 | $12K | Hold |
750
| – | – | ﹤0.01% | 434 |
|
|
2016
Q4 | $13K | Hold |
750
| – | – | ﹤0.01% | 408 |
|
|
2016
Q3 | $15K | Hold |
750
| – | – | ﹤0.01% | 392 |
|
|
2016
Q2 | $20K | Buy |
+750
| New | +$20K | 0.01% | 364 |
|